Factor V Leiden protects against blood loss and transfusion after cardiac surgery. Donahue BS, Gailani D, Higgins MS, Drinkwater DC, George AL (2003) Circulation 107: 1003-8 Relative purity of thrombin-based hemostatic agents used in surgery. Schoenecker JG, Johnson RK, Fields RC, Lesher AP, Domzalski T, Baig K, Lawson JH, Parker W (2003) J Am Coll Surg 197: 580-90 Prospective evaluation and clinical utility of on-site monitoring of coagulation in patients undergoing cardiac operation. Despotis GJ, Santoro SA, Spitznagel E, Kater KM, Cox JL, Barnes P, Lappas DG (1994) J Thorac Cardiovasc Surg 107: 271-9 Intraoperative use of low-dose recombinant activated factor VII during thoracic aortic operations. Andersen ND, Bhattacharya SD, Williams JB, Fosbol EL, Lockhart EL, Patel MB, Gaca JG, Welsby IJ, Hughes GC (2012) Ann Thorac Surg 93: 1921-8; discussion 1928-9 Mechanisms of hemostatic failure during laparoscopic nephrectomy: review of Food and Drug Administration database. Hsi RS, Saint-Elie DT, Zimmerman GJ, Baldwin DD (2007) Urology 70: 888-92 Prospective comparison of four laparoscopic vessel ligation devices. Lamberton GR, Hsi RS, Jin DH, Lindler TU, Jellison FC, Baldwin DD (2008) J Endourol 22: 2307-12
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.